| |
| |
|
| Insider
Information: |
Sofia Michael J. |
| Relationship: |
Chief Scientific Officer |
| City: |
Burnaby |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,485,121 |
|
|
Indirect Shares
|
167,162 |
|
|
| Direct
Value |
$4,054,380 |
|
|
|
Indirect Value
|
$456,352 |
|
|
| Total
Shares |
1,652,283 |
|
|
| Total
Value |
$4,510,733 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tekmira Pharmaceuticals Corp |
TKMR |
Chief Scientific Officer |
2024-02-02 |
1,485,121 |
2024-02-02 |
167,162 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2024-02-02 |
4 |
AS |
$2.31 |
$23,083 |
D/D |
(9,982) |
1,485,121 |
0 |
% |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
109,500 |
1,495,103 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
82,200 |
1,385,603 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2021-12-01 |
4 |
AS |
$5.09 |
$1,018,000 |
D/D |
(200,000) |
1,303,403 |
0 |
% |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2018-08-13 |
4/A |
S |
$9.51 |
$40,436 |
I/I |
(4,250) |
167,162 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2018-08-13 |
4 |
S |
$9.51 |
$40,436 |
D/D |
(4,250) |
1,499,153 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2018-07-11 |
4 |
AS |
$10.00 |
$100,000 |
D/D |
(10,000) |
1,503,403 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2018-07-09 |
4 |
AS |
$8.91 |
$89,060 |
D/D |
(10,000) |
1,513,403 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2018-07-06 |
4 |
AS |
$8.45 |
$84,500 |
D/D |
(10,000) |
1,523,403 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2018-07-05 |
4 |
AS |
$8.40 |
$84,000 |
D/D |
(10,000) |
1,533,403 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2018-07-03 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
1,543,403 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2017-10-03 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
1,553,403 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific Officer |
• – – |
2017-08-15 |
4 |
S |
$3.68 |
$111,000 |
I/I |
(30,000) |
171,412 |
0 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific OfficerOffice |
• – – |
2015-03-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
201,412 |
|
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
Chief Scientific OfficerOffice |
• – – |
2015-03-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,563,403 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
